Also trades as: DMAQR (NASDAQ) · $vol 0M
DMAQ NASDAQ
Deep Medicine Acquisition Corp.
1W: -68.4%
1M: -74.6%
3M: -74.6%
1Y: -71.3%
$2.96
Last traded 2024-01-31 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$12.9M
52W Range2.96-19.91
Volume73,881
Avg Volume132,219
Beta0.02
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOHumphrey P. Polanen
Employees2
SectorFinancial Services
IndustryShell Companies
IPO Date2021-12-02
595 Madison Avenue
New York City, NY 10017
US
New York City, NY 10017
US
917 289 2776
About Deep Medicine Acquisition Corp.
Deep Medicine Acquisition Corp. (DMAQ) currently operates as a non-operating entity, possessing no substantial business functions of its own. Its express purpose is to execute a business combination, which could entail a merger, an acquisition of equity or assets, or a reorganization, with one or more target companies. The firm's strategic efforts are specifically concentrated on identifying promising enterprises within the healthcare industry. Incorporated in 2020, DMAQ maintains its principal place of business in New York, New York.
Latest News
No recent news
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Bright Vision Sponso | J-Other | 150,000 | — | 2023-10-31 |
| Chiang John | 0 | — | 2022-10-15 | |
| Chiang John | 0 | — | 2022-10-15 | |
| Bright Vision Sponso | J-Other | 406,500 | $10.00 | 2021-10-29 |
| LUO WEIXUAN | 0 | — | 2021-10-26 |